世界のENG（エンドグリン前駆体）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global ENG(Endoglin Precursor) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2186 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ENG（エンドグリン前駆体）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ENG（エンドグリン前駆体）の市場動向 ・企業の競争状況、市場シェア ・ENG（エンドグリン前駆体）の種類別市場規模（95％以上、99％以上、その他） ・ENG（エンドグリン前駆体）の用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他） ・ENG（エンドグリン前駆体）の北米市場規模2016-2027（アメリカ、カナダ） ・ENG（エンドグリン前駆体）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ENG（エンドグリン前駆体）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ENG（エンドグリン前駆体）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ENG（エンドグリン前駆体）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、R&D Systems、Lifespan Biosciences、Bio-Rad、Abbexa Ltd、Boster Bio、Atlas Antibodies、Biobyt、Novus Biologicals、Aviva Systems Biology、ProSci、BioLegend） ・結論

Market Analysis and Insights: Global ENG(Endoglin Precursor) Market
The global ENG(Endoglin Precursor) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ENG(Endoglin Precursor) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ENG(Endoglin Precursor) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ENG(Endoglin Precursor) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ENG(Endoglin Precursor) market.

Global ENG(Endoglin Precursor) Scope and Market Size
ENG(Endoglin Precursor) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ENG(Endoglin Precursor) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Above 95%
Above 99%
Others

Segment by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
R&D Systems
Lifespan Biosciences
Bio-Rad
Abbexa Ltd
Boster Bio
Atlas Antibodies
Biobyt
Novus Biologicals
Bio-Rad

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ENG(Endoglin Precursor) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Above 95%
1.2.3 Above 99%
1.2.4 Others
1.3 Market by Application
1.3.1 Global ENG(Endoglin Precursor) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global ENG(Endoglin Precursor) Market Perspective (2016-2027)
2.2 ENG(Endoglin Precursor) Growth Trends by Regions
2.2.1 ENG(Endoglin Precursor) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ENG(Endoglin Precursor) Historic Market Share by Regions (2016-2021)
2.2.3 ENG(Endoglin Precursor) Forecasted Market Size by Regions (2022-2027)
2.3 ENG(Endoglin Precursor) Industry Dynamic
2.3.1 ENG(Endoglin Precursor) Market Trends
2.3.2 ENG(Endoglin Precursor) Market Drivers
2.3.3 ENG(Endoglin Precursor) Market Challenges
2.3.4 ENG(Endoglin Precursor) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top ENG(Endoglin Precursor) Players by Revenue
3.1.1 Global Top ENG(Endoglin Precursor) Players by Revenue (2016-2021)
3.1.2 Global ENG(Endoglin Precursor) Revenue Market Share by Players (2016-2021)
3.2 Global ENG(Endoglin Precursor) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ENG(Endoglin Precursor) Revenue
3.4 Global ENG(Endoglin Precursor) Market Concentration Ratio
3.4.1 Global ENG(Endoglin Precursor) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ENG(Endoglin Precursor) Revenue in 2020
3.5 ENG(Endoglin Precursor) Key Players Head office and Area Served
3.6 Key Players ENG(Endoglin Precursor) Product Solution and Service
3.7 Date of Enter into ENG(Endoglin Precursor) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ENG(Endoglin Precursor) Breakdown Data by Type
4.1 Global ENG(Endoglin Precursor) Historic Market Size by Type (2016-2021)
4.2 Global ENG(Endoglin Precursor) Forecasted Market Size by Type (2022-2027)

5 ENG(Endoglin Precursor) Breakdown Data by Application
5.1 Global ENG(Endoglin Precursor) Historic Market Size by Application (2016-2021)
5.2 Global ENG(Endoglin Precursor) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America ENG(Endoglin Precursor) Market Size (2016-2027)
6.2 North America ENG(Endoglin Precursor) Market Size by Type
6.2.1 North America ENG(Endoglin Precursor) Market Size by Type (2016-2021)
6.2.2 North America ENG(Endoglin Precursor) Market Size by Type (2022-2027)
6.2.3 North America ENG(Endoglin Precursor) Market Size by Type (2016-2027)
6.3 North America ENG(Endoglin Precursor) Market Size by Application
6.3.1 North America ENG(Endoglin Precursor) Market Size by Application (2016-2021)
6.3.2 North America ENG(Endoglin Precursor) Market Size by Application (2022-2027)
6.3.3 North America ENG(Endoglin Precursor) Market Size by Application (2016-2027)
6.4 North America ENG(Endoglin Precursor) Market Size by Country
6.4.1 North America ENG(Endoglin Precursor) Market Size by Country (2016-2021)
6.4.2 North America ENG(Endoglin Precursor) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe ENG(Endoglin Precursor) Market Size (2016-2027)
7.2 Europe ENG(Endoglin Precursor) Market Size by Type
7.2.1 Europe ENG(Endoglin Precursor) Market Size by Type (2016-2021)
7.2.2 Europe ENG(Endoglin Precursor) Market Size by Type (2022-2027)
7.2.3 Europe ENG(Endoglin Precursor) Market Size by Type (2016-2027)
7.3 Europe ENG(Endoglin Precursor) Market Size by Application
7.3.1 Europe ENG(Endoglin Precursor) Market Size by Application (2016-2021)
7.3.2 Europe ENG(Endoglin Precursor) Market Size by Application (2022-2027)
7.3.3 Europe ENG(Endoglin Precursor) Market Size by Application (2016-2027)
7.4 Europe ENG(Endoglin Precursor) Market Size by Country
7.4.1 Europe ENG(Endoglin Precursor) Market Size by Country (2016-2021)
7.4.2 Europe ENG(Endoglin Precursor) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific ENG(Endoglin Precursor) Market Size (2016-2027)
8.2 Asia-Pacific ENG(Endoglin Precursor) Market Size by Type
8.2.1 Asia-Pacific ENG(Endoglin Precursor) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ENG(Endoglin Precursor) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ENG(Endoglin Precursor) Market Size by Type (2016-2027)
8.3 Asia-Pacific ENG(Endoglin Precursor) Market Size by Application
8.3.1 Asia-Pacific ENG(Endoglin Precursor) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ENG(Endoglin Precursor) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ENG(Endoglin Precursor) Market Size by Application (2016-2027)
8.4 Asia-Pacific ENG(Endoglin Precursor) Market Size by Region
8.4.1 Asia-Pacific ENG(Endoglin Precursor) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ENG(Endoglin Precursor) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America ENG(Endoglin Precursor) Market Size (2016-2027)
9.2 Latin America ENG(Endoglin Precursor) Market Size by Type
9.2.1 Latin America ENG(Endoglin Precursor) Market Size by Type (2016-2021)
9.2.2 Latin America ENG(Endoglin Precursor) Market Size by Type (2022-2027)
9.2.3 Latin America ENG(Endoglin Precursor) Market Size by Type (2016-2027)
9.3 Latin America ENG(Endoglin Precursor) Market Size by Application
9.3.1 Latin America ENG(Endoglin Precursor) Market Size by Application (2016-2021)
9.3.2 Latin America ENG(Endoglin Precursor) Market Size by Application (2022-2027)
9.3.3 Latin America ENG(Endoglin Precursor) Market Size by Application (2016-2027)
9.4 Latin America ENG(Endoglin Precursor) Market Size by Country
9.4.1 Latin America ENG(Endoglin Precursor) Market Size by Country (2016-2021)
9.4.2 Latin America ENG(Endoglin Precursor) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa ENG(Endoglin Precursor) Market Size (2016-2027)
10.2 Middle East & Africa ENG(Endoglin Precursor) Market Size by Type
10.2.1 Middle East & Africa ENG(Endoglin Precursor) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ENG(Endoglin Precursor) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ENG(Endoglin Precursor) Market Size by Type (2016-2027)
10.3 Middle East & Africa ENG(Endoglin Precursor) Market Size by Application
10.3.1 Middle East & Africa ENG(Endoglin Precursor) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ENG(Endoglin Precursor) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ENG(Endoglin Precursor) Market Size by Application (2016-2027)
10.4 Middle East & Africa ENG(Endoglin Precursor) Market Size by Country
10.4.1 Middle East & Africa ENG(Endoglin Precursor) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ENG(Endoglin Precursor) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific ENG(Endoglin Precursor) Introduction
11.1.4 Thermo Fisher Scientific Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 R&D Systems
11.2.1 R&D Systems Company Details
11.2.2 R&D Systems Business Overview
11.2.3 R&D Systems ENG(Endoglin Precursor) Introduction
11.2.4 R&D Systems Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.2.5 R&D Systems Recent Development
11.3 Lifespan Biosciences
11.3.1 Lifespan Biosciences Company Details
11.3.2 Lifespan Biosciences Business Overview
11.3.3 Lifespan Biosciences ENG(Endoglin Precursor) Introduction
11.3.4 Lifespan Biosciences Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.3.5 Lifespan Biosciences Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad ENG(Endoglin Precursor) Introduction
11.4.4 Bio-Rad Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.4.5 Bio-Rad Recent Development
11.5 Abbexa Ltd
11.5.1 Abbexa Ltd Company Details
11.5.2 Abbexa Ltd Business Overview
11.5.3 Abbexa Ltd ENG(Endoglin Precursor) Introduction
11.5.4 Abbexa Ltd Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.5.5 Abbexa Ltd Recent Development
11.6 Boster Bio
11.6.1 Boster Bio Company Details
11.6.2 Boster Bio Business Overview
11.6.3 Boster Bio ENG(Endoglin Precursor) Introduction
11.6.4 Boster Bio Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.6.5 Boster Bio Recent Development
11.7 Atlas Antibodies
11.7.1 Atlas Antibodies Company Details
11.7.2 Atlas Antibodies Business Overview
11.7.3 Atlas Antibodies ENG(Endoglin Precursor) Introduction
11.7.4 Atlas Antibodies Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.7.5 Atlas Antibodies Recent Development
11.8 Biobyt
11.8.1 Biobyt Company Details
11.8.2 Biobyt Business Overview
11.8.3 Biobyt ENG(Endoglin Precursor) Introduction
11.8.4 Biobyt Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.8.5 Biobyt Recent Development
11.9 Novus Biologicals
11.9.1 Novus Biologicals Company Details
11.9.2 Novus Biologicals Business Overview
11.9.3 Novus Biologicals ENG(Endoglin Precursor) Introduction
11.9.4 Novus Biologicals Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.9.5 Novus Biologicals Recent Development
11.10 Aviva Systems Biology
11.10.1 Aviva Systems Biology Company Details
11.10.2 Aviva Systems Biology Business Overview
11.10.3 Aviva Systems Biology ENG(Endoglin Precursor) Introduction
11.10.4 Aviva Systems Biology Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.10.5 Aviva Systems Biology Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci ENG(Endoglin Precursor) Introduction
11.11.4 ProSci Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.11.5 ProSci Recent Development
11.12 BioLegend
11.12.1 BioLegend Company Details
11.12.2 BioLegend Business Overview
11.12.3 BioLegend ENG(Endoglin Precursor) Introduction
11.12.4 BioLegend Revenue in ENG(Endoglin Precursor) Business (2016-2021)
11.12.5 BioLegend Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ENG(Endoglin Precursor) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Above 95%
Table 3. Key Players of Above 99%
Table 4. Key Players of Others
Table 5. Global ENG(Endoglin Precursor) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global ENG(Endoglin Precursor) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global ENG(Endoglin Precursor) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global ENG(Endoglin Precursor) Market Share by Regions (2016-2021)
Table 9. Global ENG(Endoglin Precursor) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global ENG(Endoglin Precursor) Market Share by Regions (2022-2027)
Table 11. ENG(Endoglin Precursor) Market Trends
Table 12. ENG(Endoglin Precursor) Market Drivers
Table 13. ENG(Endoglin Precursor) Market Challenges
Table 14. ENG(Endoglin Precursor) Market Restraints
Table 15. Global ENG(Endoglin Precursor) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global ENG(Endoglin Precursor) Market Share by Players (2016-2021)
Table 17. Global Top ENG(Endoglin Precursor) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ENG(Endoglin Precursor) as of 2020)
Table 18. Ranking of Global Top ENG(Endoglin Precursor) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by ENG(Endoglin Precursor) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players ENG(Endoglin Precursor) Product Solution and Service
Table 22. Date of Enter into ENG(Endoglin Precursor) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global ENG(Endoglin Precursor) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global ENG(Endoglin Precursor) Revenue Market Share by Type (2016-2021)
Table 26. Global ENG(Endoglin Precursor) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global ENG(Endoglin Precursor) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global ENG(Endoglin Precursor) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global ENG(Endoglin Precursor) Revenue Market Share by Application (2016-2021)
Table 30. Global ENG(Endoglin Precursor) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global ENG(Endoglin Precursor) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America ENG(Endoglin Precursor) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America ENG(Endoglin Precursor) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America ENG(Endoglin Precursor) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America ENG(Endoglin Precursor) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America ENG(Endoglin Precursor) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America ENG(Endoglin Precursor) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe ENG(Endoglin Precursor) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe ENG(Endoglin Precursor) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe ENG(Endoglin Precursor) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe ENG(Endoglin Precursor) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe ENG(Endoglin Precursor) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe ENG(Endoglin Precursor) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific ENG(Endoglin Precursor) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific ENG(Endoglin Precursor) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific ENG(Endoglin Precursor) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific ENG(Endoglin Precursor) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific ENG(Endoglin Precursor) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific ENG(Endoglin Precursor) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America ENG(Endoglin Precursor) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America ENG(Endoglin Precursor) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America ENG(Endoglin Precursor) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America ENG(Endoglin Precursor) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America ENG(Endoglin Precursor) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America ENG(Endoglin Precursor) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa ENG(Endoglin Precursor) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa ENG(Endoglin Precursor) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa ENG(Endoglin Precursor) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa ENG(Endoglin Precursor) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa ENG(Endoglin Precursor) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa ENG(Endoglin Precursor) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific ENG(Endoglin Precursor) Product
Table 65. Thermo Fisher Scientific Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. R&D Systems Company Details
Table 68. R&D Systems Business Overview
Table 69. R&D Systems ENG(Endoglin Precursor) Product
Table 70. R&D Systems Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 71. R&D Systems Recent Development
Table 72. Lifespan Biosciences Company Details
Table 73. Lifespan Biosciences Business Overview
Table 74. Lifespan Biosciences ENG(Endoglin Precursor) Product
Table 75. Lifespan Biosciences Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 76. Lifespan Biosciences Recent Development
Table 77. Bio-Rad Company Details
Table 78. Bio-Rad Business Overview
Table 79. Bio-Rad ENG(Endoglin Precursor) Product
Table 80. Bio-Rad Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 81. Bio-Rad Recent Development
Table 82. Abbexa Ltd Company Details
Table 83. Abbexa Ltd Business Overview
Table 84. Abbexa Ltd ENG(Endoglin Precursor) Product
Table 85. Abbexa Ltd Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 86. Abbexa Ltd Recent Development
Table 87. Boster Bio Company Details
Table 88. Boster Bio Business Overview
Table 89. Boster Bio ENG(Endoglin Precursor) Product
Table 90. Boster Bio Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 91. Boster Bio Recent Development
Table 92. Atlas Antibodies Company Details
Table 93. Atlas Antibodies Business Overview
Table 94. Atlas Antibodies ENG(Endoglin Precursor) Product
Table 95. Atlas Antibodies Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 96. Atlas Antibodies Recent Development
Table 97. Biobyt Company Details
Table 98. Biobyt Business Overview
Table 99. Biobyt Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 100. Biobyt Recent Development
Table 101. Novus Biologicals Company Details
Table 102. Novus Biologicals Business Overview
Table 103. Novus Biologicals ENG(Endoglin Precursor) Product
Table 104. Novus Biologicals Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 105. Novus Biologicals Recent Development
Table 106. Aviva Systems Biology Company Details
Table 107. Aviva Systems Biology Business Overview
Table 108. Aviva Systems Biology ENG(Endoglin Precursor) Product
Table 109. Aviva Systems Biology Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 110. Aviva Systems Biology Recent Development
Table 111. ProSci Company Details
Table 112. ProSci Business Overview
Table 113. ProSci ENG(Endoglin Precursor) Product
Table 114. ProSci Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 115. ProSci Recent Development
Table 116. BioLegend Company Details
Table 117. BioLegend Business Overview
Table 118. BioLegend ENG(Endoglin Precursor) Product
Table 119. BioLegend Revenue in ENG(Endoglin Precursor) Business (2016-2021) & (US$ Million)
Table 120. BioLegend Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ENG(Endoglin Precursor) Market Share by Type: 2020 VS 2027
Figure 2. Above 95% Features
Figure 3. Above 99% Features
Figure 4. Others Features
Figure 5. Global ENG(Endoglin Precursor) Market Share by Application: 2020 VS 2027
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Bioscience Research Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. ENG(Endoglin Precursor) Report Years Considered
Figure 11. Global ENG(Endoglin Precursor) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global ENG(Endoglin Precursor) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global ENG(Endoglin Precursor) Market Share by Regions: 2020 VS 2027
Figure 14. Global ENG(Endoglin Precursor) Market Share by Regions (2022-2027)
Figure 15. Global ENG(Endoglin Precursor) Market Share by Players in 2020
Figure 16. Global Top ENG(Endoglin Precursor) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ENG(Endoglin Precursor) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by ENG(Endoglin Precursor) Revenue in 2020
Figure 18. Global ENG(Endoglin Precursor) Revenue Market Share by Type (2016-2021)
Figure 19. Global ENG(Endoglin Precursor) Revenue Market Share by Type (2022-2027)
Figure 20. North America ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America ENG(Endoglin Precursor) Market Share by Type (2016-2027)
Figure 22. North America ENG(Endoglin Precursor) Market Share by Application (2016-2027)
Figure 23. North America ENG(Endoglin Precursor) Market Share by Country (2016-2027)
Figure 24. United States ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe ENG(Endoglin Precursor) Market Share by Type (2016-2027)
Figure 28. Europe ENG(Endoglin Precursor) Market Share by Application (2016-2027)
Figure 29. Europe ENG(Endoglin Precursor) Market Share by Country (2016-2027)
Figure 30. Germany ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific ENG(Endoglin Precursor) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific ENG(Endoglin Precursor) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific ENG(Endoglin Precursor) Market Share by Region (2016-2027)
Figure 40. China ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America ENG(Endoglin Precursor) Market Share by Type (2016-2027)
Figure 48. Latin America ENG(Endoglin Precursor) Market Share by Application (2016-2027)
Figure 49. Latin America ENG(Endoglin Precursor) Market Share by Country (2016-2027)
Figure 50. Mexico ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa ENG(Endoglin Precursor) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa ENG(Endoglin Precursor) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa ENG(Endoglin Precursor) Market Share by Country (2016-2027)
Figure 56. Turkey ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE ENG(Endoglin Precursor) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 60. R&D Systems Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 61. Lifespan Biosciences Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 62. Bio-Rad Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 63. Abbexa Ltd Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 64. Boster Bio Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 65. Atlas Antibodies Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 66. Biobyt Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 67. Novus Biologicals Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 68. Aviva Systems Biology Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 69. ProSci Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 70. BioLegend Revenue Growth Rate in ENG(Endoglin Precursor) Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---